Celldex Therapeutics Inc (NASDAQ:CLDX)

20.80
Delayed Data
As of 3:59pm ET
 +0.09 / +0.43%
Today’s Change
1.77
Today|||52-Week Range
30.17
+18.72%
Year-to-Date
Could Celldex Be a Millionaire-Maker Stock?
Apr 10 / MotleyFool.com - Paid Partner Content
ACADIA (ACAD) Gets CRL From FDA for Nuplazid sNDA, Shares Down
Apr 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close20.71
Today’s open20.30
Day’s range19.71 - 20.85
Volume34,241
Average volume (3 months)744,143
Market cap$821.6M
Data as of 3:59pm ET, 04/12/2021

Growth & Valuation

Earnings growth (last year)+75.78%
Earnings growth (this year)+49.48%
Earnings growth (next 5 years)--
Revenue growth (last year)-62.54%
P/E ratioNM
Price/Sales9.05
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
AWHAspira Women's Healt...-0.24-3.85%
TRILTrillium Therapeutic...-0.58-5.57%
----
VIVOMeridian Bioscience ...-1.01-4.03%
Data as of 3:59pm ET, 04/12/2021

Financials

Next reporting dateMay 11, 2021
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$3.6M
Annual profit (last year)-$50.9M
Net profit margin-1,423.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Hampton, New Jersey

Forecasts